Project Home Practical guide Digital clinical measures Innovation roadmap CRS Innovation Roadmap Are you looking to develop a CRS de-risking product? This product development roadmap leads you through a strategic process to turn your vision into reality. Key milestones help you build products that deliver increasing value for patients and healthcare providers. Use this roadmap […]| DATAcc by DiMe
Until recently, cellular therapy to treat blood cancers and disorders required patients to be hospitalized during treatment. Now, Atrium Health Levine Cancer offers lifesaving cellular therapy on an outpatient basis, helping patients have a better quality of life during treatment.| atriumhealth.org
Project Home Practical guide Digital clinical measures Innovation roadmap Common digital clinical measures to de-risk CRS Our community of experts has identified a set of common digital clinical measures that are essential for developing Cytokine Release Syndrome (CRS) de-risking products. We’ve also developed an ontology to help you standardize data collection for assessing CRS onset […]| DATAcc by DiMe
Project Home Practical guide Digital clinical measures Innovation roadmap Leveraging digital innovations to support the development of CRS de-risking products Learn more here Today, Cytokine Release Syndrome (CRS) requires regular clinical oversight through extended hospitalizations, creating barriers to care and limiting patient access to vital immunotherapies. Digital health technologies (DHTs) have matured to a point […]| DATAcc by DiMe
DATAcc Projects DATAcc projects focus on advancing digital health measurements by developing new evidentiary frameworks and new measures in a pre-competitive environment. As a DATAcc project partner, you will be part of a project to transform lives with digital health measurement. Your organization will also become a member of the DATAcc steering committee and community. […]| DATAcc by DiMe
